Cargando…
Sensitization of Chemo-Resistant Human Chronic Myeloid Leukemia Stem-Like Cells to Hsp90 Inhibitor by SIRT1 Inhibition
Development of effective therapeutic strategies to eliminate cancer stem-like cells (CSCs), which play a major role in drug resistance and disease recurrence, is critical to improve cancer treatment outcomes. The current investigation was undertaken to examine the effectiveness of the combination tr...
Autores principales: | Kim, Hak-Bong, Lee, Su-Hoon, Um, Jee-Hyun, Kim, Mi-Ju, Hyun, Suh-Kyung, Gong, Eun-Ji, Oh, Won Keun, Kang, Chi-Dug, Kim, Sun-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495410/ https://www.ncbi.nlm.nih.gov/pubmed/26157347 http://dx.doi.org/10.7150/ijbs.10896 |
Ejemplares similares
-
Sensitization of multidrug-resistant human cancer cells to Hsp90 inhibitors by down-regulation of SIRT1
por: Kim, Hak-Bong, et al.
Publicado: (2015) -
Sensitization of multidrug-resistant cancer cells to Hsp90 inhibitors by NSAIDs-induced apoptotic and autophagic cell death
por: Moon, Hyun-Jung, et al.
Publicado: (2018) -
Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia
por: Khajapeer, Kalubai Vari, et al.
Publicado: (2015) -
Nonsteroidal Anti-inflammatory Drugs Sensitize CD44-Overexpressing Cancer Cells to Hsp90 Inhibitor Through Autophagy Activation
por: Moon, Hyun-Jung, et al.
Publicado: (2019) -
Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL
por: Lee, Su-Hoon, et al.
Publicado: (2016)